CareDx (CDNA) Competitors $19.32 +0.42 (+2.22%) Closing price 04:00 PM EasternExtended Trading$19.12 -0.20 (-1.01%) As of 07:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends CDNA vs. RDNT, SHC, SGRY, BTSG, PRVA, CON, WGS, LFST, VCYT, and ARDTShould you be buying CareDx stock or one of its competitors? The main competitors of CareDx include RadNet (RDNT), Sotera Health (SHC), Surgery Partners (SGRY), BrightSpring Health Services (BTSG), Privia Health Group (PRVA), Concentra Group Holdings Parent (CON), GeneDx (WGS), LifeStance Health Group (LFST), Veracyte (VCYT), and Ardent Health Partners (ARDT). These companies are all part of the "healthcare" industry. CareDx vs. RadNet Sotera Health Surgery Partners BrightSpring Health Services Privia Health Group Concentra Group Holdings Parent GeneDx LifeStance Health Group Veracyte Ardent Health Partners CareDx (NASDAQ:CDNA) and RadNet (NASDAQ:RDNT) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, valuation, media sentiment, dividends, analyst recommendations, community ranking and risk. Is CDNA or RDNT more profitable? RadNet has a net margin of -0.25% compared to CareDx's net margin of -45.90%. RadNet's return on equity of 4.29% beat CareDx's return on equity.Company Net Margins Return on Equity Return on Assets CareDx-45.90% -53.70% -30.42% RadNet -0.25%4.29%1.45% Do institutionals & insiders hold more shares of CDNA or RDNT? 77.9% of RadNet shares are held by institutional investors. 4.9% of CareDx shares are held by company insiders. Comparatively, 5.1% of RadNet shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Does the MarketBeat Community favor CDNA or RDNT? CareDx received 88 more outperform votes than RadNet when rated by MarketBeat users. However, 66.17% of users gave RadNet an outperform vote while only 65.87% of users gave CareDx an outperform vote. CompanyUnderperformOutperformCareDxOutperform Votes44265.87% Underperform Votes22934.13% RadNetOutperform Votes35466.17% Underperform Votes18133.83% Do analysts rate CDNA or RDNT? CareDx presently has a consensus price target of $31.83, suggesting a potential upside of 64.77%. RadNet has a consensus price target of $76.75, suggesting a potential upside of 55.84%. Given CareDx's higher possible upside, analysts plainly believe CareDx is more favorable than RadNet.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CareDx 0 Sell rating(s) 3 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.57RadNet 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 2 Strong Buy rating(s) 3.40 Which has more volatility and risk, CDNA or RDNT? CareDx has a beta of 1.95, meaning that its stock price is 95% more volatile than the S&P 500. Comparatively, RadNet has a beta of 1.85, meaning that its stock price is 85% more volatile than the S&P 500. Which has preferable earnings & valuation, CDNA or RDNT? RadNet has higher revenue and earnings than CareDx. CareDx is trading at a lower price-to-earnings ratio than RadNet, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCareDx$333.79M3.21-$190.28M$1.0218.94RadNet$1.83B1.99$3.04M$0.031,641.67 Does the media prefer CDNA or RDNT? In the previous week, RadNet had 10 more articles in the media than CareDx. MarketBeat recorded 14 mentions for RadNet and 4 mentions for CareDx. CareDx's average media sentiment score of 1.24 beat RadNet's score of 1.01 indicating that CareDx is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CareDx 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive RadNet 9 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryRadNet beats CareDx on 11 of the 19 factors compared between the two stocks. Remove Ads Get CareDx News Delivered to You Automatically Sign up to receive the latest news and ratings for CDNA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CDNA vs. The Competition Export to ExcelMetricCareDxMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.07B$2.91B$5.70B$8.12BDividend YieldN/A22.90%4.41%4.09%P/E Ratio-7.1613.4524.1518.94Price / Sales3.21209.60394.5890.48Price / CashN/A57.5638.1634.64Price / Book4.004.697.104.43Net Income-$190.28M-$22.21M$3.19B$247.05M7 Day Performance2.22%3.98%1.79%1.48%1 Month Performance-13.32%-9.02%2.32%-6.41%1 Year Performance94.76%2.72%14.79%3.33% CareDx Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CDNACareDx3.4419 of 5 stars$19.32+2.2%$31.83+64.8%+88.6%$1.07B$333.79M-7.16740Positive NewsRDNTRadNet4.2556 of 5 stars$49.21+5.7%$76.75+56.0%+5.3%$3.64B$1.83B-702.918,970Analyst UpgradeInsider TradePositive NewsHigh Trading VolumeSHCSotera Health2.6211 of 5 stars$11.93+2.9%$15.92+33.4%+1.6%$3.38B$1.10B47.723,000Gap DownSGRYSurgery Partners2.7233 of 5 stars$24.39+3.3%$36.63+50.2%-13.4%$3.11B$3.11B-50.8113,500BTSGBrightSpring Health Services2.1522 of 5 stars$17.45+0.2%$21.67+24.2%+101.4%$3.05B$11.27B-67.1235,000Gap DownPRVAPrivia Health Group3.8986 of 5 stars$23.24-2.1%$26.67+14.7%+11.4%$2.80B$1.74B232.421,102Analyst ForecastCONConcentra Group Holdings ParentN/A$21.04+1.2%$28.38+34.8%N/A$2.68B$1.90B13.9411,000Ex-DividendAnalyst ForecastPositive NewsWGSGeneDx2.4122 of 5 stars$94.62-3.9%$72.33-23.6%+1,036.4%$2.66B$305.45M-48.271,200Positive NewsLFSTLifeStance Health Group2.6255 of 5 stars$6.89-0.5%$8.63+25.3%+9.1%$2.65B$1.25B-26.489,325Insider TradePositive NewsVCYTVeracyte4.0101 of 5 stars$31.28-0.7%$43.00+37.5%+47.3%$2.44B$445.76M-208.53790Analyst ForecastPositive NewsARDTArdent Health PartnersN/A$14.02+0.9%$21.18+51.1%N/A$2.00B$5.97B0.0024,200 Remove Ads Related Companies and Tools Related Companies RadNet Alternatives Sotera Health Alternatives Surgery Partners Alternatives BrightSpring Health Services Alternatives Privia Health Group Alternatives Concentra Group Holdings Parent Alternatives GeneDx Alternatives LifeStance Health Group Alternatives Veracyte Alternatives Ardent Health Partners Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CDNA) was last updated on 3/21/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CareDx, Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share CareDx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.